Last updated: April 13, 2023
Sponsor: N/A
Overall Status: Active - Recruiting
Phase
1
Condition
Alzheimer's Disease
Dementia
Mild Cognitive Impairment
Treatment
N/AClinical Study ID
TX306092
IRB-22-109
Ages 40-100 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- This study focuses specifically on people experiencing a cognitive decline from Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) or language deficits resulting from Primary Progressive Aphasia (PPA). To be included in the study, participants with MCI and AD must have a history of progressive memory impairment, and PPA must have a history of a progressive language deficit.
Exclusion
Exclusion Criteria:
- Mild Cognitive Impairment, Alzheimer's Disease and Primary Progressive Aphasia participants must not suffer from any other type of neurological disease. Participants must not be pregnant. Furthermore, participants must not have hair braids or other hair products that cannot be removed. These hair products will interfere with the EEG signal during the recording.
Study Design
Total Participants: 200
Study Start date:
May 01, 2022
Estimated Completion Date:
April 30, 2024
Study Description
Connect with a study center
Speech Language and Music Lab
Dallas, Texas 75235
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.